Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Debt / NOTE 1.000% 9/1
-
Market price (% of par)
-
116.97%
-
Total 13F principal
-
$903,721,020
-
Principal change
-
-$36,641,960
-
Total reported market value
-
$1,058,398,169
-
Number of holders
-
57
-
Value change
-
-$27,889,611
-
Number of buys
-
23
-
Number of sells
-
37
Institutional Holders of ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1 as of Q3 2024
As of 30 Sep 2024,
ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1 was held by
57 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$903,721,020
in principal (par value) of the bond.
The largest 10 bondholders included
Voya Investment Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Aequim Alternative Investments LP, LAZARD ASSET MANAGEMENT LLC, BlackRock, Inc., Calamos Advisors LLC, Davidson Kempner Capital Management LP, Invesco Ltd., FMR LLC, and DeepCurrents Investment Group LLC.
This page lists
58
institutional bondholders reporting positions
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.